We are live on
!
Find out more
LW
Linscomb Wealth Portfolio holdings
AUM
$2.31B
Turnover
16.38%
1-Year Est. Return
28.23%
This Fund
S&P 500
This Quarter
Est. Return
-12.57%
1 Year Est. Return
+28.23%
3 Year Est. Return
+75.24%
5 Year Est. Return
+83.81%
10 Year Est. Return
+223.31%
AUM
$1.74B
AUM Growth
-$349M
(-17%)
Cap. Flow
-$86.7M
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
46.17%
Holding
351
New
4
Increased
96
Reduced
161
Closed
63
Avg Time Held Equity + Options
5.5
years
Top 10 Avg Time Held Equity + Options
6.6
years
Top 20 Avg Time Held Equity + Options
4.9
years
Avg Time Held Equity only
5.6
years
Top 10 Avg Time Held Equity only
6.6
years
Top 20 Avg Time Held Equity only
4.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$9.68M |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$2.77M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$2.73M |
| 4 |
Fidelity Total Bond ETF
FBND
|
+$2.55M |
| 5 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$1.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$44.9M |
| 2 |
WisdomTree US MidCap Dividend Fund
DON
|
+$7.1M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$4.06M |
| 4 |
Cincinnati Financial
CINF
|
+$3.99M |
| 5 |
Coca-Cola
KO
|
+$3.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.45% |
| 2 | Technology | 8.64% |
| 3 | Healthcare | 6.23% |
| 4 | Financials | 5.54% |
| 5 | Energy | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $187M | 10.74% |
4,593,932
+217,853
| +5% | +$9.68M |
2013 Q2
36 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$887B
| $145M | 8.31% |
382,439
+6,625
| +2% | +$2.73M |
2013 Q2
36 quarters
|
|
|
3
WisdomTree US MidCap Dividend Fund
DON
$3.86B
| $89.7M | 5.14% |
2,300,450
-168,453
| -7% | -$7.1M |
2013 Q2
36 quarters
|
|
4
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $86.6M | 4.96% |
1,913,155
-53,840
| -3% | -$2.66M |
2013 Q2
36 quarters
|
|
|
5
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $64M | 3.67% |
2,159,445
+86,335
| +4% | +$2.77M |
2020 Q4
6 quarters
|
|
6
iShares MSCI EAFE ETF
EFA
$76.8B
| $61.9M | 3.55% |
990,247
+8,757
| +0.9% | +$596K |
2013 Q2
36 quarters
|
|
7
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $51.1M | 2.93% |
270,864
-5,327
| -2% | -$1.09M |
2013 Q2
36 quarters
|
|
8
State Street SPDR S&P Dividend ETF
SDY
$21.4B
| $47.3M | 2.71% |
398,219
+639
| +0.2% | +$79.7K |
2013 Q2
36 quarters
|
|
|
9
ExxonMobil
XOM
$718B
| $37.3M | 2.14% |
436,064
-497,521
| -53% | -$44.9M |
2013 Q2
36 quarters
|
|
10
WisdomTree US High Dividend Fund
DHS
$1.59B
| $35.2M | 2.02% |
427,873
-3,503
| -0.8% | -$306K |
2013 Q2
36 quarters
|
|
11
Microsoft
MSFT
$4T
| $32.7M | 1.87% |
127,181
-3,899
| -3% | -$1.06M |
2013 Q2
36 quarters
|
|
12
Apple
AAPL
$4.99T
| $24.8M | 1.42% |
181,181
-14,430
| -7% | -$2.19M |
2013 Q2
36 quarters
|
|
13
Chevron
CVX
$431B
| $14.6M | 0.84% |
100,932
-202
| -0.2% | -$33.4K |
2013 Q2
36 quarters
|
|
14
AbbVie
ABBV
$504B
| $14.5M | 0.83% |
94,698
-6,782
| -7% | -$1.04M |
2013 Q2
36 quarters
|
|
15
JPMorgan Chase
JPM
$887B
| $14.3M | 0.82% |
126,587
+6,911
| +6% | +$856K |
2013 Q2
36 quarters
|
|
16
Johnson & Johnson
JNJ
$611B
| $13.5M | 0.77% |
76,038
-11,500
| -13% | -$2.05M |
2013 Q2
36 quarters
|
|
17
Procter & Gamble
PG
$366B
| $12.9M | 0.74% |
89,768
+1,964
| +2% | +$295K |
2013 Q2
36 quarters
|
|
18
WisdomTree US SmallCap Earnings Fund
EES
$680M
| $12.7M | 0.73% |
309,373
-52,011
| -14% | -$2.31M |
2013 Q3
35 quarters
|
|
19
Vanguard High Dividend Yield ETF
VYM
$81.2B
| $12.6M | 0.72% |
124,006
-5,944
| -5% | -$644K |
2013 Q2
36 quarters
|
|
20
Qualcomm
QCOM
$188B
| $12.5M | 0.71% |
97,607
-1,515
| -2% | -$206K |
2013 Q2
36 quarters
|
|
21
iShares International Select Dividend ETF
IDV
$8.25B
| $12.1M | 0.69% |
443,843
+5,706
| +1% | +$172K |
2013 Q3
35 quarters
|
|
22
iShares Select Dividend ETF
DVY
$23B
| $12M | 0.69% |
101,653
-6,362
| -6% | -$796K |
2013 Q2
36 quarters
|
|
23
Abbott
ABT
$181B
| $12M | 0.69% |
110,019
-985
| -0.9% | -$112K |
2013 Q2
36 quarters
|
|
24
Pfizer
PFE
$169B
| $11.9M | 0.68% |
226,767
-4,438
| -2% | -$226K |
2013 Q2
36 quarters
|
|
25
RTX Corp
RTX
$250B
| $11.7M | 0.67% |
121,688
-3,091
| -2% | -$297K |
2013 Q2
36 quarters
|
|
Similar funds
EFP
HHGA
GGH
Linscomb Wealth's Q2 2022 Portfolio in Review
As of Q2 2022, Linscomb Wealth held 351 positions worth $1.74B, down 17% from $2.09B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Linscomb Wealth withdrew a net $86.7M in Q2 2022, closing 63 positions and reducing 161 holdings. Its most notable exit was LHC Group LLC, an estimated $4.06M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 56% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Linscomb Wealth opened a new position in PIMCO Active Bond Exchange-Traded Fund worth $1.69M.
- Linscomb Wealth's largest Q2 2022 buy was PIMCO Active Bond Exchange-Traded Fund: 17,780 shares worth $1.69M.
- Linscomb Wealth added most to Vanguard FTSE Developed Markets ETF in Q2 2022, an estimated $9.68M increase.
- Linscomb Wealth's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $44.9M.
- Linscomb Wealth fully exited LHC Group LLC in Q2 2022, selling an estimated $4.06M.
- Linscomb Wealth's ten largest holdings make up 46% of its $1.74B portfolio in Q2 2022.
- Linscomb Wealth opened 4 new positions and closed 63 in Q2 2022.
- Linscomb Wealth's portfolio value fell 17% quarter-over-quarter to $1.74B.
Based on Linscomb Wealth's 13F filing for Q2 2022, filed 15 Aug 2022.